MyMyelomaTeam

Are you wondering what to expect when switching from Daratumumab (Dara) plus lenalidomide maintenance to lenalidomide alone due to low immunoglobulins?

This is a situation some people with myeloma face, and it's a reasonable clinical decision. Low immunoglobulins can increase infection risk, so adjusting the regimen makes Show Full Answer

Are you wondering what to expect when switching from Daratumumab (Dara) plus lenalidomide maintenance to lenalidomide alone due to low immunoglobulins?

This is a situation some people with myeloma face, and it's a reasonable clinical decision. Low immunoglobulins can increase infection risk, so adjusting the regimen makes sense. Here's what's generally known about lenalidomide-only maintenance:

- Lenalidomide is the current standard of care for myeloma maintenance and is FDA-approved for this purpose after a bone marrow transplant
- Studies show it can significantly extend the time before myeloma gets worse — around 57 months in remission after transplant, compared to 30 months without it
- Research suggests it may actually become more effective the longer you take it, with some patients reaching MRD-negative status over time
- Sticking closely to the schedule is really important for the best outcomes Common side effects to watch for on lenalidomide include:

- Changes in blood counts
- Fatigue
- Digestive issues (diarrhea or constipation)
- Higher risk of blood clots
- Muscle cramps, rash, or shortness of breath

Your care team will monitor these regularly. Always report anything uncomfortable — they can often help manage symptoms effectively.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Multiple Myeloma Maintenance Therapy: 6 Facts

Treatments

Darzalex